About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
Apr 22, 2020... As he discusses in this video, Prof. Sarel Fleishman of the Department of Biomolecular Sciences is supporting multiple lines of coronavirus research at Weizmann – including his own.
Apr 26, 2020... In this videoconference hosted by Weizmann Canada, Profs. Uri Alon and Ron Milo present their bioinformatics-based exit strategy, which Prof. Milo describes as “‘biology by the numbers’ meets the coronavirus.”
Apr 27, 2020... Public health expert Prof. Gabi Barbash outlines the pandemic’s many unknowns: How many people are asymptomatic and yet spreading the virus? Why do some patients have mild symptoms, while others become severely ill? Are recovered patients with coronavirus antibodies now immune?
Apr 28, 2020... Dr. Ori Avinoam of Weizmann’s Department of Biomolecular Sciences presents an overview of his lab’s coronavirus research. His team has created a pseudovirus, which has all the elements of the coronavirus but is not infectious.
May 04, 2020... In this video, Profs. Ron Milo and Uri Alon succinctly and clearly explain their “intermittent work” strategy for restarting the economy without triggering a new wave of COVID infections.
May 06, 2020... A year and a half ago, biochemist Prof. Ruth Arnon, Israel Prize recipient for medicine and past president of the Israel Academy of Sciences and Humanities, received an email from the editor of a science journal. The editor asked whether she planned to attend a conference on multiple sclerosis that was to take place a few days later. Arnon, who was one of the scientists responsible for the research that led to the MS treatment, Copaxone, said she wouldn’t be attending, but was sending a researcher from her lab at the Weizmann Institute of Science.
Jun 02, 2020... In this special update from his home in New York City, CEO Dave Doneson discusses the Weizmann Institute’s remarkable coronavirus response. Dave shares how the Institute has rapidly shifted its focus to address the pandemic, transforming into one of the world’s leading hubs of COVID-19 research. Weizmann scientists are fighting this disease on a variety of fronts, offering hope and optimism for us all.
May 17, 2020... Dr. Nir London discusses the “COVID Moonshot” project in this videoconference. The global initiative, which currently includes nine partners, aims to develop a “cheap and safe” antiviral treatment for COVID on a much faster timeline than traditional drug discovery.
May 12, 2020... There’s an obvious risk to reopening the economy during the pandemic, even in places where the number of COVID-19 cases is dropping: As more people come back into contact, cases could surge again, and businesses could be forced to shut down a second time. South Korea is seeing a new spike in cases after the outbreak seemed to be under control. In China, new cases have emerged in Wuhan, the original epicenter of the virus. But an adjustment to work schedules—along with social distancing and other tools like contact tracing—could help businesses that can’t work remotely to potentially reopen safely.
May 24, 2020...
Researchers have a plan to mitigate the risk of a second wave of coronavirus infections — a scenario many experts think is likely. For some, it's an alternating cycle of four days at the office, then 10 days under lockdown. For others, it's a switch-off between 50 days under stay-at-home orders and 30 days of relative freedom.
In all likelihood, these tactics won't prevent cases from rising again.
©2023 American Committee for the Weizmann Institute of Science
FOR THE FOURTH CONSECUTIVE YEAR
